[go: up one dir, main page]

BRPI0408100A - composição de insulina injetável de atuação longa e processos de produção e de utilização da mesma - Google Patents

composição de insulina injetável de atuação longa e processos de produção e de utilização da mesma

Info

Publication number
BRPI0408100A
BRPI0408100A BRPI0408100-5A BRPI0408100A BRPI0408100A BR PI0408100 A BRPI0408100 A BR PI0408100A BR PI0408100 A BRPI0408100 A BR PI0408100A BR PI0408100 A BRPI0408100 A BR PI0408100A
Authority
BR
Brazil
Prior art keywords
production
use processes
composition
mammal
long acting
Prior art date
Application number
BRPI0408100-5A
Other languages
English (en)
Inventor
Wladimir Sabetsky
Original Assignee
Technology Dev Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Dev Company Ltd filed Critical Technology Dev Company Ltd
Publication of BRPI0408100A publication Critical patent/BRPI0408100A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

"COMPOSIçãO DE INSULINA INJETáVEL DE ATUAçãO LONGA E PROCESSOS DE PRODUçãO E DE UTILIZAçãO DA MESMA". A presente invenção refere-se a um processo de diminuição da glicose no sangue em um mamífero que inclui a injeção de uma quantidade terapeuticamente eficaz de micropartículas de dextrana cristalizadas e insulina no mamífero para diminuir a glicose no sangue do mamífero. A composição pode ser uma composição de uma fase ou multifásica estruturada para a liberação controlada de insulina ao longo de um período maior de tempo.
BRPI0408100-5A 2003-03-04 2004-03-04 composição de insulina injetável de atuação longa e processos de produção e de utilização da mesma BRPI0408100A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US45124503P 2003-03-04 2003-03-04
US46760103P 2003-05-05 2003-05-05
US46901703P 2003-05-09 2003-05-09
US49509703P 2003-08-15 2003-08-15
PCT/IB2004/000984 WO2004078198A1 (en) 2003-03-04 2004-03-04 Long acting injectable insulin composition and methods of making and using thereof

Publications (1)

Publication Number Publication Date
BRPI0408100A true BRPI0408100A (pt) 2006-03-01

Family

ID=32831112

Family Applications (3)

Application Number Title Priority Date Filing Date
BRPI0408105-6A BRPI0408105A (pt) 2003-03-04 2004-03-04 sistema de distribuição para droga e terapia celular
BRPI0408100-5A BRPI0408100A (pt) 2003-03-04 2004-03-04 composição de insulina injetável de atuação longa e processos de produção e de utilização da mesma
BRPI0408097-1A BRPI0408097A (pt) 2003-03-04 2004-03-04 composição de insulina oral e processos para a produção e para o uso da mesma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0408105-6A BRPI0408105A (pt) 2003-03-04 2004-03-04 sistema de distribuição para droga e terapia celular

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0408097-1A BRPI0408097A (pt) 2003-03-04 2004-03-04 composição de insulina oral e processos para a produção e para o uso da mesma

Country Status (17)

Country Link
US (5) US20040234615A1 (pt)
EP (3) EP1603589A1 (pt)
JP (3) JP2006519253A (pt)
KR (3) KR20060014027A (pt)
AR (1) AR046485A1 (pt)
AT (1) ATE485051T1 (pt)
AU (3) AU2004216911A1 (pt)
BR (3) BRPI0408105A (pt)
CA (3) CA2518136A1 (pt)
DE (1) DE602004029630D1 (pt)
EA (3) EA200501420A1 (pt)
EC (3) ECSP056077A (pt)
MX (1) MXPA05009493A (pt)
NO (3) NO20054533L (pt)
PT (1) PT1454630E (pt)
TW (1) TW200529869A (pt)
WO (3) WO2004078198A1 (pt)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ES2425392T3 (es) 2002-03-20 2013-10-15 Mannkind Corporation Cartucho para un aparato de inhalación
JP2006519253A (ja) * 2003-03-04 2006-08-24 ザ・テクノロジー・デヴェロップメント・カンパニー・リミテッド 長時間作用性注射用インスリン組成物およびその製造および使用方法
EP2107069B1 (en) * 2003-08-05 2013-01-16 Novo Nordisk A/S Novel insulin derivatives
TW200603843A (en) * 2004-04-20 2006-02-01 Technology Dev Company Ltd Tissue enhancement implant and method
ES2385934T3 (es) 2004-08-20 2012-08-03 Mannkind Corporation Catálisis de la síntesis de dicetopiperazina.
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
FR2880272A1 (fr) * 2005-01-04 2006-07-07 Jean Marc Ruiz Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication
EP1931311A4 (en) * 2005-08-29 2010-12-08 Tuo Jin POLYSACCHARIDE MICRO PARTICLES WITH BIOLOGICAL AGENTS: THEIR PREPARATION AND USES
US7799344B2 (en) * 2005-09-14 2010-09-21 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
PL1969004T3 (pl) 2005-12-28 2012-01-31 Novo Nordisk As Kompozycje zawierające acylowaną insulinę i cynk oraz sposób wytwarzania tych kompozycji
SE529040C2 (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
US8039431B2 (en) 2006-02-22 2011-10-18 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
JP2010505616A (ja) * 2006-10-06 2010-02-25 プレジデント アンド フェロウズ オブ ハーバード カレッジ 材料の化学的に指向された静電的自己集成体
WO2008152106A1 (en) 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
EP2025334A1 (en) * 2007-07-25 2009-02-18 OctoPlus Sciences B.V. Sustained release drug delivery system for repeated administration
DK2293833T3 (en) 2008-06-13 2016-05-23 Mannkind Corp DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
FR2940802A1 (fr) * 2008-10-10 2010-07-09 Adocia Complexe entre l'insuline humaine et un polymere amphiphile et utilisation de ce complexe pour la preparation d'une formulation d'insuline humaine rapide.
PT2349324T (pt) 2008-10-17 2017-12-06 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
KR20110085985A (ko) 2008-10-30 2011-07-27 노보 노르디스크 에이/에스 하루 한번 주사 빈도보다 적은 인슐린 주사를 사용한 진성 당뇨병의 치료
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
FR2943538B1 (fr) * 2009-03-27 2011-05-20 Adocia Formulation a action rapide d'insuline recombinante humaine
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
US8551528B2 (en) 2009-06-12 2013-10-08 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9068182B2 (en) * 2009-07-28 2015-06-30 Corning Incorporated Synthetic polysaccharide microcarriers for culturing cells
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
US9016147B2 (en) 2009-11-03 2015-04-28 Mannkind Corporation Apparatus and method for simulating inhalation efforts
WO2011058083A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
RS55378B1 (sr) 2010-08-30 2017-03-31 Sanofi Aventis Deutschland Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
DK2632478T3 (da) 2010-10-27 2019-10-07 Novo Nordisk As Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
MY180552A (en) 2011-04-01 2020-12-02 Mannkind Corp Blister package for pharmaceutical cartridges
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012293312A1 (en) * 2011-08-07 2014-06-05 Transgene Biotek Ltd A novel method for peroral delivery of insulin and its analogues for therapeutic usage
HRP20151068T1 (hr) 2011-08-29 2016-01-01 Sanofi-Aventis Deutschland Gmbh Farmaceutska kombinacija za upotrebu za glikemijsku kontrolu kod pacijenata s dijabetesom tipa 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP2776053A1 (en) 2011-10-24 2014-09-17 MannKind Corporation Methods and compositions for treating pain
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
SG11201500218VA (en) 2012-07-12 2015-03-30 Mannkind Corp Dry powder drug delivery systems and methods
US9157939B2 (en) * 2012-08-09 2015-10-13 Infineon Technologies Ag System and device for determining electric voltages
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
JP6322642B2 (ja) 2012-11-13 2018-05-09 アドシア 置換されたアニオン性化合物を含有する速効型インスリン製剤
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
AU2014247167B2 (en) 2013-04-03 2018-11-22 Sanofi Treatment of diabetes mellitus by long–acting formulations of insulins
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
JP6200698B2 (ja) * 2013-06-18 2017-09-20 ニュートリー株式会社 嚥下造影検査食
MX394255B (es) 2013-07-18 2025-03-24 Mannkind Corp Composiciones farmaceuticas en polvo seco estables al calor y metodos
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
FR3020947B1 (fr) 2014-05-14 2018-08-31 Adocia Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
RU2014120626A (ru) * 2014-05-22 2015-11-27 Владимир Андреевич Сабецкий Инсулинсодержащий препарат пролонгированного действия
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN105617362B (zh) * 2014-10-27 2021-05-11 中国医学科学院药物研究所 一种新型的胰岛素－磷脂－壳聚糖自组装微粒载体及其制剂
TWI758239B (zh) 2014-12-12 2022-03-21 德商賽諾菲阿凡提斯德意志有限公司 甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
FR3043557B1 (fr) 2015-11-16 2019-05-31 Adocia Composition a action rapide d'insuline comprenant un citrate substitue
WO2017141262A1 (en) 2016-02-19 2017-08-24 Indian Institute Of Technology, Bombay Orally administrable pharmaceutical preparation containing protein
RU2647466C1 (ru) * 2016-12-01 2018-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ) Способ получения нативного белка пролонгирующего действия в составе полимерных наносфер и резорбируемых микросфер для доставки
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
KR20200056359A (ko) 2020-04-29 2020-05-22 김용원 퀵보드 등 승용기구바퀴(회전자)에 설치되는 바퀴덮개(고정자)에 설치하는 발전기
KR20200056360A (ko) 2020-04-29 2020-05-22 김용원 자전거바퀴(회전자)와 바퀴덮개(고정자)에 설치하는 발전기
KR20200056361A (ko) 2020-05-04 2020-05-22 김용원 발판보드에 설치하는 발전기
KR20200060307A (ko) 2020-05-06 2020-05-29 김용원 자전거와 리어 캐리어에 설치하는 발전장치들
KR20200060308A (ko) 2020-05-07 2020-05-29 김용원 수상보드에 설치하는 발전기
KR20200060309A (ko) 2020-05-08 2020-05-29 김용원 헬스차량에 설치하는 발전기
KR20200062092A (ko) 2020-05-11 2020-06-03 김용원 수차와 공기 컴프레서를 이용한 공기 터빈구조 발전기와 바퀴구조 발전기를 합한 발전기
KR20200061324A (ko) 2020-05-11 2020-06-02 김용원 보트에 설치하는 발전기
KR20200068614A (ko) 2020-05-26 2020-06-15 김용원 펠티어소자를 이용한 공기, 물 컨디션너 조절장치 내에 설치한 발전기
KR20200083393A (ko) 2020-06-16 2020-07-08 김용원 "공기 터빈구조 발전기"와 "바퀴구조를 합한 발전기"를 "발열소자를 이용한 발전기"와 적용 양방향 모터(양방향 프로펠러)를 양방향공기추진기(Propullor)와 결합 장착한 드론
KR20200088241A (ko) 2020-06-30 2020-07-22 김용원 역방향 모터(양방향 프로펠러)의 추진에 맞는 관성을 이기는 팬이 없는 양방향공기추진기(Propullor)를 장착한 드론
KR20200108392A (ko) 2020-08-31 2020-09-18 김용원 전동 오토바이 모터의 정격에 맞는 오토바이바퀴에 회전자와 물받이 고정자 발전기를 설치한 오토바이에 모터가 장착된 항공기 공기추진기(Propulsor)와 장착한 드론의 프로퓰러(Propullor)를 장착하는 제조기술)
WO2022149125A1 (en) * 2021-01-07 2022-07-14 Ramot At Tel Aviv University Ltd. Methods and compositions for melanin synthesis
KR20210018367A (ko) 2021-01-26 2021-02-17 김용원 전동 오토바이에 설치한 모터가 장착된 항공기 공기추진기와 장착한 프로퓰러(Propullor)로 구성한 오토에어크라프트(Autoaircraft)
KR20210029730A (ko) 2021-02-22 2021-03-16 김용원 산사태에 대비, 대응하는 에어 레이어들 블록들이 형성된 거대장비들(에어 레이어들 블록들)
KR20210040852A (ko) 2021-03-24 2021-04-14 김용원 전동에어버스
KR20210043513A (ko) 2021-03-26 2021-04-21 김용원 전동에어버스에 설치하는 연기(분연), 재 포집장치
KR20210045369A (ko) 2021-03-31 2021-04-26 김용원 전기 에어 카
KR20210049046A (ko) 2021-04-13 2021-05-04 김용원 전기에어버스를 강풍, 태풍에 구조하는 보조날개와 보조출입문 장치
KR20210055643A (ko) 2021-04-27 2021-05-17 김용원 모터가 장착된 회전축에 다량의 회전자바퀴와 다량의 고정자바퀴발전기를 설치한 전동보드
KR20210072739A (ko) 2021-05-27 2021-06-17 김용원 의료용 전동보드
KR20210080293A (ko) 2021-06-11 2021-06-30 김용원 바퀴 사이 발전기 케이스
CN115702880B (zh) * 2021-08-12 2023-11-03 山东新时代药业有限公司 一种重组甘精胰岛素注射液及其制备工艺
KR20220016234A (ko) 2022-01-14 2022-02-08 김용원 공기추진기(공기펌프와 공기터빈)를 장착한 3륜 자전거
KR20220038026A (ko) 2022-02-24 2022-03-25 김용원 4합 공기터빈 : 공기터빈 축에 1. 인너 팬들의 인너 실린더와 2. 아웃터 팬들의 아웃터 실린더와 3. 양쪽 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들에 덕트팬들과 덕트흡입구와 4 1. 인너 실린더들과 2. 아웃터 실린더들의 사이에 아웃터 팬들의 3. 덕트팬들에 블레이드와 블레이드 외부 형틀
KR20220056159A (ko) 2022-04-04 2022-05-04 김용원 물탱크 내의 스팀집 슈퍼히터에 전력공급한 스팀공급으로 스팀터빈을 구동하는 것과 슈퍼히터로 스팀을 공급하는 스팀청소기에 발전기들을 설치하는 것과 공기터빈의 흡입구들의 공기필터들 설치와 펠티에소자를 이용한 냉온 공기배출과 얼음제조기 시스템
KR20220056835A (ko) 2022-04-18 2022-05-06 김용원 공기추진기(공기펌프와 여러 공기터빈들)들을 장착한 수상 자전거
KR20220076421A (ko) 2022-05-11 2022-06-08 김용원 공기추진기(공기펌프와 공기터빈들)들을 장착한 페달자전차
KR20220080053A (ko) 2022-05-27 2022-06-14 김용원 다중 에어 레이어 튜브보트
AU2024219315A1 (en) * 2023-02-08 2025-09-25 Inventera Inc. Polysaccharide cross-linked colloidal particles squeezable between internal body structures without aggregation, and use thereof as modifier for in vivo injection
KR20250070006A (ko) 2025-04-23 2025-05-20 김용원 수륙양용 전동보드

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
US4963526A (en) * 1984-05-09 1990-10-16 Synthetic Blood Corporation Oral insulin and a method of making the same
EP0247077A1 (en) 1985-10-22 1987-12-02 ROBINSON, Eric Process for cell immobilisation
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
USRE37950E1 (en) * 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
US5618531A (en) * 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
US5840290A (en) * 1996-05-30 1998-11-24 University Of Florida Research Foundation Injectable bio-active glass in a dextran suspension
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6395302B1 (en) * 1996-11-19 2002-05-28 Octoplus B.V. Method for the preparation of microspheres which contain colloidal systems
EP0842657A1 (en) * 1996-11-19 1998-05-20 OctoPlus B.V. Microspheres for controlled release and processes to prepare these microspheres
WO1998022093A1 (en) 1996-11-19 1998-05-28 Octoplus B.V. Process for the preparation of a controlled release system
FR2764514B1 (fr) * 1997-06-13 1999-09-03 Biopharmex Holding Sa Implant injectable en sous-cutane ou intradermique a bioresorbabilite controlee pour la chirurgie reparatrice ou plastique et la dermatologie esthetique
WO1999002107A1 (en) * 1997-07-10 1999-01-21 Us Biomaterials Corporation Moldable bioactive compositions
US6194006B1 (en) * 1998-12-30 2001-02-27 Alkermes Controlled Therapeutics Inc. Ii Preparation of microparticles having a selected release profile
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
JP4865947B2 (ja) * 1999-02-19 2012-02-01 ウニフェルシテイト ユトレヒト ステレオコンプレックスヒドロゲル
FR2794649B1 (fr) * 1999-06-11 2003-04-11 Solutions Biomateriau a base d'un derive de dextrane insolubilise et d'un facteur de croissance, son procede de preparation et ses applications
WO2001023563A2 (en) * 1999-09-27 2001-04-05 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
EP1184032A1 (en) * 2000-08-31 2002-03-06 OctoPlus B.V. Dextran hydrogels
FR2814951B1 (fr) * 2000-10-06 2003-01-17 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation
JP2004513914A (ja) * 2000-11-16 2004-05-13 ヤゴテック　アーゲー 非経口的投与可能な微粒子
GB2374010B (en) * 2001-02-26 2004-12-29 Council Scient Ind Res Novel vitamin B12 - biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines
EP1270012A1 (en) * 2001-06-21 2003-01-02 Pfizer Products Inc. Use of pulmonary administration of insulin for treatment of diabetes
JP2006519253A (ja) * 2003-03-04 2006-08-24 ザ・テクノロジー・デヴェロップメント・カンパニー・リミテッド 長時間作用性注射用インスリン組成物およびその製造および使用方法
SE529040C2 (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin

Also Published As

Publication number Publication date
BRPI0408097A (pt) 2006-02-14
EP1603589A1 (en) 2005-12-14
KR20060014027A (ko) 2006-02-14
AU2004216909A1 (en) 2004-09-16
NO20054539D0 (no) 2005-10-03
TW200529869A (en) 2005-09-16
PT1454630E (pt) 2010-12-15
KR20060015469A (ko) 2006-02-17
AU2004216908A1 (en) 2004-09-16
DE602004029630D1 (de) 2010-12-02
US20040234616A1 (en) 2004-11-25
NO20054534L (no) 2005-11-29
ECSP056077A (es) 2006-08-30
ATE485051T1 (de) 2010-11-15
US20110097385A1 (en) 2011-04-28
AR046485A1 (es) 2005-12-14
MXPA05009493A (es) 2006-08-11
AU2004216911A1 (en) 2004-09-16
WO2004078197A1 (en) 2004-09-16
US20100166855A1 (en) 2010-07-01
CA2518143A1 (en) 2004-09-16
US20100167985A1 (en) 2010-07-01
EA200501422A1 (ru) 2006-04-28
WO2004078196A1 (en) 2004-09-16
WO2004078198A1 (en) 2004-09-16
ECSP056076A (es) 2006-08-30
NO20054533D0 (no) 2005-10-03
JP2006519253A (ja) 2006-08-24
EA200501421A1 (ru) 2006-04-28
US20040234615A1 (en) 2004-11-25
EP1454631A1 (en) 2004-09-08
CA2518148A1 (en) 2004-09-16
EP1454630B1 (en) 2010-10-20
CA2518136A1 (en) 2004-09-16
KR20060015472A (ko) 2006-02-17
EA200501420A1 (ru) 2006-04-28
US7544656B2 (en) 2009-06-09
ECSP056078A (es) 2006-08-30
NO20054534D0 (no) 2005-10-03
BRPI0408105A (pt) 2006-03-01
NO20054539L (no) 2005-12-01
EP1454630A1 (en) 2004-09-08
JP2006519840A (ja) 2006-08-31
NO20054533L (no) 2005-12-02
JP2006519252A (ja) 2006-08-24

Similar Documents

Publication Publication Date Title
BRPI0408100A (pt) composição de insulina injetável de atuação longa e processos de produção e de utilização da mesma
BRPI0410953A (pt) composições de depósito elastoméricas que podem ser implantadas, usos das mesmas e processo de produção
BR9911656A (pt) Composição farmacêutica, processos para prevenção ou tratamento de diabetes em um mamìfero, para prevenção ou tratamento de complicações diabéticas em um mamìfero e para prevenção ou tratamento da tolerância a glicose prejudicada em um mamìfero, uso de um sensibilizador de insulina, e, proceso para reduzir os efeitos colaterais de um sensibilizador de insulina ou/ e um anorético administrado a um mamìfero diabético
AR041913A1 (es) Formulaciones de deposito de liberacion controlada
BRPI0508233A (pt) derivados de isoquinolina e métodos para emprego destes
BR0215029A (pt) Molécula de insulina, uso da mesma, composição, uso desta, microcristal, processo para prepará-lo, uso deste, e, métodos para preparar uma molécula de insulina, para tratar hiperglicemia, e para tratar diabetes mellitus
AR049955A1 (es) Composiciones y metodos para el tratamiento de trastornos metabolicos
BRPI0910198A2 (pt) composição para administração a partir de um sítio local de um agente baseado em nucleotídeos e método para tratar um sujeito sofrendo de uma doença requerendo tratamento local com um agente baseado em nucleotídeo.
BR0109553A (pt) Método para o melhoramento de sinalização de ilhota em diabetes melito e para sua prevenção
BR9602626A (pt) Composto método para o tratamento de uma doença ou condição dependente da fosforilase do glicogénio método para evitar uma lesão isquémica do miocárdio composição farmacéutica e processo para a preparação de um composto
BRPI0414254A (pt) composição farmacêutica, e, métodos para fabricar uma composição farmacêutica, para o tratamento de pelo menos uma doença e para controlar a taxa de dissolução de uma formulação
BRPI0513243A (pt) composições oftálmicas e métodos para tratar condições oftálmicas
WO2007067504A3 (en) Lactam compounds and methods of using the same
DE60127970D1 (de) Zusammensetzung, welche ein antifolate und ein methylmalonsäuresenkendes mittel enthält
PT1066056E (pt) Composto de ferro-dextrano para utilizacao como componente de uma composicao terapeutica para a profilaxia ou tratamento da carencia de ferro processo de producao do referido composto de ferro-dextrano e utilizacao desse mesmo composto na preparacao de uma composicao terapeutica de administracao parenterica
BRPI0607703A2 (pt) compostos de isoquinolina e métodos de uso dos mesmos
BRPI0606191A2 (pt) compostos de amino e carboxamido tetracìclicos e métodos do seu uso
CL2006002332A1 (es) Metodo para preparar una composicion medica que comprende preparar una composicion para tratamiento y agregar al menos un agente a dicha composicion, en donde los agentes tienen la propiedad de aumentar o al menos mantener la viscosidad de la composi
BRPI0506493A (pt) combinações terapêuticas
BRPI0704542B8 (pt) composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento
Bellot et al. Repeated monosialoganglioside administration attenuates behavioral sensitization to amphetamine
Cattaneo The platelet P2Y receptors as targets for new antithrombotic drugs
WO2007115092A3 (en) 10-substituted cytisine derivatives and methods of use thereof
WO2007109312A3 (en) Disease modifying anti-arthritic activity of 2-methoxyestradiol
MX2007012991A (es) Formas solidas cristalinas y amorfas de halofenato (-) y metodoss relacionados a las mismas.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.